chemotherapy

Review

Systemic Therapy for Early-Stage Breast Cancer: What the Plastic Surgeon Should Know

03/27/2021

Chad M. Teven, MD, Daniel B. Schmid, MD, Mark Sisco, MD, James Ward, MD, and Michael A. Howard, MD

Chad M. Teven, MD, Daniel B. Schmid, ...

Types, indications, and common regimens of systemic forms of therapy offered in early-stage breast cancer are reviewed, with further detail on the mechanism of action, approved uses, major toxicities, and relevance to breast reconstruction of...

Types, indications, and common...

03/27/2021

ePlasty

Use of Negative Pressure Wound Therapy with Instillation and Dwell Times for Complex Wound Management in a Cancer Care Setting

Introduction: Wound management represents a major healthcare cost and with inadequate intervention has a significant impact on patient quality of life. Oncological wounds have a delayed r...

06/10/2019

Research in Review

Chemotherapy May Be Overused Among Patients With Colon Cancer

02/09/2017

JCP Editors

Chemotherapy may be overused among young and middle-aged patients with colon cancer, according to a study published in JAMA Surgery (published online January 25, 2017; doi: 10.1001/jamasurg.2016.5050). ----- Related...

...

02/09/2017

Journal of Clinical Pathways

Research in Review

PET Scans During Induction Chemo Contribute to Complete Response for Esophageal Cancer

01/19/2017

JCP Editors

Positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate...

...

01/19/2017

Journal of Clinical Pathways

Research in Review

Two-Drug Regimen Without Chemotherapy May Treat Type of Lymphoma

01/06/2017

JCP Editors

Patients with mantle cell lymphoma may be able to forego chemotherapy in favor of induction treatment with a two-drug regimen, according to new research presented at the American Society of Hematology (ASH) annual...

...

01/06/2017

Journal of Clinical Pathways

Research in Review

First-Line Pembrolizumab for NSCLC Improves HRQoL Versus Chemotherapy

12/08/2016

JCP Editors

Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...

...

12/08/2016

Journal of Clinical Pathways

Research in Review

Pembrolizumab Better Than Chemotherapy for Urothelial Cancer

11/14/2016

JCP Editors

An anti-PD-1 therapy significantly improves overall survival (OS) compared with chemotherapy in previously treated patients with advanced bladder (urothelial) cancer, according to a study presented at the Society for...

An...

11/14/2016

Journal of Clinical Pathways